Stryker Corporation Stock price

Equities

SYK

US8636671013

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 04:00:02 2024-03-28 pm EDT 5-day change 1st Jan Change
357.9 USD -0.23% Intraday chart for Stryker Corporation +1.23% +19.51%
Sales 2024 * 22.17B Sales 2025 * 23.8B Capitalization 136B
Net income 2024 * 3.87B Net income 2025 * 4.24B EV / Sales 2024 * 6.5 x
Net Debt 2024 * 7.76B Net Debt 2025 * 5.36B EV / Sales 2025 * 5.96 x
P/E ratio 2024 *
36 x
P/E ratio 2025 *
32.3 x
Employees 52,000
Yield 2024 *
0.89%
Yield 2025 *
0.96%
Free-Float 93.46%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.23%
1 week+1.23%
Current month+2.52%
1 month+1.73%
3 months+19.64%
6 months+30.89%
Current year+19.51%
More quotes
1 week
348.81
Extreme 348.805
359.50
1 month
347.08
Extreme 347.0786
361.41
Current year
292.43
Extreme 292.43
361.41
1 year
249.98
Extreme 249.98
361.41
3 years
188.84
Extreme 188.84
361.41
5 years
124.54
Extreme 124.54
361.41
10 years
75.78
Extreme 75.78
361.41
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 11-04-24
Director of Finance/CFO 62 02-12-31
Compliance Officer - 16-12-31
Members of the board TitleAgeSince
Director/Board Member 80 73-12-31
Director/Board Member 65 18-05-01
Director/Board Member 89 77-01-31
More insiders
Date Price Change Volume
24-03-28 357.9 -0.23% 1 074 735
24-03-27 358.7 +2.38% 1,404,675
24-03-26 350.4 -0.19% 785,798
24-03-25 351 -0.45% 792,529
24-03-22 352.6 -0.25% 1,105,369

Delayed Quote Nyse, March 28, 2024 at 04:00 pm EDT

More quotes
Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
358.7 USD
Average target price
356.8 USD
Spread / Average Target
-0.54%
Consensus
  1. Stock
  2. Equities
  3. Stock Stryker Corporation - Nyse